| Detected | Trial | Change |
|---|---|---|
| 2026-06-06 | NCT07104032 IGNITE: Study of Tirabrutinib vs Rituximab/Temozolomide for Relapsed/Refractory Primary… |
Trial sites expanded: 10 -> 14 locations |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 3 | |||
| NCT06696716 | ONO-4059 Study in Patients With Steroid-resistant Pemphigus | Pemphigus | Recruiting |
| NCT07104032 | IGNITE: Study of Tirabrutinib vs Rituximab/Temozolomide for Relapsed/Refractory Primary… | Relapsed/Refractory Primary Central Nervous System Lymphoma | Recruiting |
| Phase 2 | |||
| NCT04947319 | Study of Tirabrutinib (ONO-4059) in Patients With Primary Central Nervous System Lymphoma… | Refractory Primary Central Nervous System Lymphoma | Active, Not Recruiting |
| Phase 1 | |||
| NCT07198087 | A Study to Investigate the Pharmacokinetics of Tirabrutinib in Participants With Mild… | Primary Central Nervous System Lymphoma (PCNSL) | Active, Not Recruiting |